Skip to content

Transcutaneous Electrical Muscle Stimulation In Chronic Obstructive Pulmonary Disease (COPD)

Transcutaneous Electrical Muscle Stimulation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01226342
Enrollment
19
Registered
2010-10-22
Start date
2009-01-31
Completion date
2009-10-31
Last updated
2013-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Chronic obstructive pulmonary disease

Brief summary

Transcutaneous electrical muscle stimulation (TCEMS) is well established intervention for rehabilitation of clinically stable patients with chronic obstructive pulmonary disease. The investigators have conceived this study to test whether TCEMS is feasible and tolerated by patients experiencing severe physical and psychical challenge of acutely exacerbated COPD.

Interventions

On the first hospitalization day patients received lower extremity TCEMS. We used GymnaUniphy device (GymnaUniphy N.V., 2004, 3740 Bilzen, Belgium) with four surface patch electrodes applied over each lower extremity quadriceps muscle. Patients were in the supine position and were advised to relax during sessions. A prespecified program for lower extremity strength training in sessions of 25 minutes, twice a day (first training in the morning, second in the afternoon, with minimal time difference of 6 hours) was performed six days per week during the hospitalization.

Sponsors

The University Clinic of Pulmonary and Allergic Diseases Golnik
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* chronic obstructive pulmonary disease GOLD stage III or IV * acute exacerbation of the disease

Exclusion criteria

* contraindications for transcutaneous electrical muscle stimulation

Design outcomes

Primary

MeasureTime frameDescription
Scores on the feasibility scale10 days (avarage time from admission to discharge)Patients will be followed from admission until discharge

Secondary

MeasureTime frameDescription
Scores on the patient satisfaction scale10 days (avarage time from admission to discharge)Patients will be followed from admission until discharge
Number of patients with adverse events as a measure of Safety and tolerability10 days (avarage time from admission to discharge)Patients will be followed from admission until discharge
Health related quality of life on the St. George respiratory questionnaire10 days (avarage time from admission to discharge)Patients will be followed from admission until discharge
Dyspnea on the MRC dyspnea scale10 days (avarage time from admission to discharge)Patients will be followed from admission until discharge
Patient symptom scores on the Functional assessment of chronic illness therapy questionaire10 days (avarage time from admission to discharge)Patients will be followed from admission until discharge

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026